The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ACHILLION PHARMACEUTICALS IN COM 00448Q201 8,255 5,191,600 SH   SOLE   5,191,600 0 0
AGILYSYS INC COM 00847J105 75,782 5,284,648 SH   SOLE   5,284,648 0 0
ECLIPSE RES CORP COM 27890G100 1,839 1,751,046 SH   SOLE   1,751,046 0 0
GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 3,942 96,040 SH   SOLE   96,040 0 0
MAXWELL TECHNOLOGIES INC COM 577767106 5,643 2,725,992 SH   SOLE   2,725,992 0 0
SKYLINE CHAMPION CORPORATION COM 830830105 81,379 5,539,759 SH   SOLE   5,539,759 0 0
YATRA ONLINE INC ORD SHS G98338109 7,793 1,938,559 SH   SOLE   1,938,559 0 0